- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Eiko Lifesciences Ltd — Board Meeting, 31-10-2025: Board Meeting
31-10-2025 | 05:55 pm
31-10-2025 | 05:55 pm
Eiko Lifesciences Board approved financial results. Consolidated H1 revenue reached ₹22.38 Cr, with Q2 revenue at ₹11.67 Cr. Profit after tax for H1 was ₹1.99 Cr, and ₹1.08 Cr for Q2.
No comments yet. Be the first to comment!